Analytical Data
-
基因名
ERVK-5
- Application
-
别名
HERV-K(II) Gag protein (HERV-K_3q12.3 provirus ancestral Gag polyprotein) (Gag polyprotein)
-
种属
Human
-
表达系统
E. coli
-
标签
N- His & C- Myc
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q9HDB9
-
表达区间
2-667aa
-
分子量
80.9 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
ERVK-5 is a member of the Endogenous Retrovirus K (ERVK) family, which has gained attention in recent years due to its potential role in various biological processes and diseases. Originating from ancient retroviral infections in human ancestors, ERVK genes, including ERVK-5, can influence immune responses, cell differentiation, and tumorigenesis. Researchers have been particularly interested in the expression patterns of ERVK-5 in different tissues, as well as its potential contributions to the pathogenesis of diseases such as cancer and autoimmune disorders. Recent studies have highlighted the dual functionality of ERVK-5, showing that it can both promote and inhibit tumor growth, depending on the cellular context. Moreover, its expression has been associated with poor prognosis in certain cancer types, making it a potential biomarker for disease progression. The ability to create recombinant ERVK-5 proteins has opened up new avenues for understanding its molecular mechanisms and interactions. Investigating these recombinant proteins is crucial for elucidating the role of ERVK-5 in various physiological and pathological contexts, and could facilitate the development of novel therapeutic strategies targeting ERVK-5 related pathways. Thus, research into ERVK-5 not only deepens our understanding of human biology but also holds promise for innovative approaches in disease management and treatment.
